Tyrosine-protein kinase BTK
Also known as: AGMX1, ATK, BPK, BTK
Function
Non-receptor tyrosine kinase indispensable for B lymphocyte development, differentiation and signaling. Binding of antigen to the B-cell antigen receptor (BCR) triggers signaling that ultimately leads to B-cell activation. After BCR engagement and activation at the plasma membrane, phosphorylates PLCG2 at several sites, igniting the downstream signaling pathway through calcium mobilization, followed by activation of the protein kinase C (PKC) family members. PLCG2 phosphorylation is performed in close cooperation with the adapter protein B-cell linker protein BLNK. BTK acts as a platform to bring together a diverse array of signaling proteins and is implicated in cytokine receptor signaling pathways. Plays an important role in the function of immune cells of innate as well as adaptive immunity, as a component of the Toll-like receptors (TLR) pathway. The TLR pathway acts as a primary surveillance system for the detection of pathogens and are crucial to the activation of host defense. Especially, is a critical molecule in regulating TLR9 activation in splenic B-cells. Within the TLR pathway, induces tyrosine phosphorylation of TIRAP which leads to TIRAP degradation. BTK also plays a critical role in transcription regulation. Induces the activity of NF-kappa-B, which is involved in regulating the expression of hundreds of genes. BTK is involved on the signaling pathway linking TLR8 and TLR9 to NF-kappa-B. Acts as an activator of NLRP3 inflammasome assembly by mediating phosphorylation of NLRP3. Transiently phosphorylates transcription factor GTF2I on tyrosine residues in response to BCR. GTF2I then translocates to the nucleus to bind regulatory enhancer elements to modulate gene expression. ARID3A and NFAT are other transcriptional target of BTK. BTK is required for the formation of functional ARID3A DNA-binding complexes. There is however no evidence that BTK itself binds directly to DNA. BTK has a dual role in the regulation of apoptosis. Plays a role in STING1-mediated induction of type I interferon (IFN) response by phosphorylating DDX41.
Classification
- Family (Pfam)
- PF00779 BTK, PF00169 PH, PF07714 PK_Tyr_Ser-Thr, PF00017 SH2, PF00018 SH3_1
- InterPro
- BTK_SH3, Kinase-like_dom_sf, Non-receptor_tyrosine_kinases, PH-like_dom_sf, PH_domain, Prot_kinase_dom, Protein_kinase_ATP_BS, Ser-Thr/Tyr_kinase_cat_dom, SH2, SH2_dom_sf, SH3-like_dom_sf, SH3_domain, Tyr_kinase_AS, Tyr_kinase_cat_dom, Znf_Btk_motif
- Functional cluster
- Serine/Threonine Protein Kinases
Experimental structures · PDB · 133
- 1AWW NMR
- 1AWX NMR
- 1B55 X-ray 2.40A
- 1BTK X-ray 1.60A
- 1BWN X-ray 2.10A
- 1K2P X-ray 2.10A
- 1QLY NMR
- 2GE9 NMR
- 2Z0P X-ray 2.58A
- 3GEN X-ray 1.60A
- 3K54 X-ray 1.94A
- 3OCS X-ray 1.80A
- … and 121 more
A predicted model is available from AlphaFold.
Gene Ontology · 54
- GO:0005737 cytoplasm
- GO:0031410 cytoplasmic vesicle
- GO:0005829 cytosol
- GO:0045121 membrane raft
- GO:0005634 nucleus
- GO:0048471 perinuclear region of cytoplasm
- GO:0005886 plasma membrane
- GO:0005524 ATP binding
- GO:0042802 identical protein binding
- GO:0004715 non-membrane spanning protein tyrosine kinase activity
- GO:0005547 phosphatidylinositol-3,4,5-trisphosphate binding
- GO:0016004 phospholipase activator activity
- GO:0043274 phospholipase binding
- GO:0004713 protein tyrosine kinase activity
- GO:0008270 zinc ion binding
- GO:0002250 adaptive immune response
- GO:0097190 apoptotic signaling pathway
- GO:0042113 B cell activation
- GO:0050853 B cell receptor signaling pathway
- GO:0019722 calcium-mediated signaling
- GO:0071226 cellular response to molecule of fungal origin
- GO:0034614 cellular response to reactive oxygen species
- GO:0006351 DNA-templated transcription
- GO:1990959 eosinophil homeostasis
- GO:0038095 Fc-epsilon receptor signaling pathway
- GO:0002553 histamine secretion by mast cell
- GO:0045087 innate immune response
- GO:0035556 intracellular signal transduction
- GO:0007498 mesoderm development
- GO:0061516 monocyte proliferation
- GO:0002755 MyD88-dependent toll-like receptor signaling pathway
- GO:0050869 negative regulation of B cell activation
- GO:0032693 negative regulation of interleukin-10 production
- GO:0070664 negative regulation of leukocyte proliferation
- GO:0001780 neutrophil homeostasis
- GO:0018108 peptidyl-tyrosine phosphorylation
- GO:0045579 positive regulation of B cell differentiation
- GO:0030890 positive regulation of B cell proliferation
- GO:0043123 positive regulation of canonical NF-kappaB signal transduction
- GO:0141111 positive regulation of cGAS/STING signaling pathway
- GO:0002639 positive regulation of immunoglobulin production
- GO:0150153 positive regulation of interleukin-17A production
- GO:0032755 positive regulation of interleukin-6 production
- GO:1900227 positive regulation of NLRP3 inflammasome complex assembly
- GO:0050766 positive regulation of phagocytosis
- GO:1901647 positive regulation of synoviocyte proliferation
- GO:0032760 positive regulation of tumor necrosis factor production
- GO:0001812 positive regulation of type I hypersensitivity
- GO:0001805 positive regulation of type III hypersensitivity
- GO:0030167 proteoglycan catabolic process
- GO:0002902 regulation of B cell apoptotic process
- GO:0002721 regulation of B cell cytokine production
- GO:0032496 response to lipopolysaccharide
- GO:0050852 T cell receptor signaling pathway
Disease associations
- Bruton-type agammaglobulinemia MONDO:0010421
- isolated growth hormone deficiency type III MONDO:0010615
Drugs targeting this protein · 22
- IBRUTINIB inhibitor
- SPEBRUTINIB BESYLATE inhibitor
- RILZABRUTINIB inhibitor
- ACALABRUTINIB inhibitor
- BMS-986142 inhibitor
- ZANUBRUTINIB inhibitor
- FENEBRUTINIB inhibitor
- TIRABRUTINIB inhibitor
- EVOBRUTINIB inhibitor
- RITLECITINIB inhibitor
- POSELTINIB inhibitor
- VECABRUTINIB inhibitor
- BRANEBRUTINIB inhibitor
- ABIVERTINIB inhibitor
- ABIVERTINIB MALEATE inhibitor
- ACALABRUTINIB MALEATE inhibitor
- ELSUBRUTINIB inhibitor
- ORELABRUTINIB inhibitor
- TOLEBRUTINIB inhibitor
- EDRALBRUTINIB inhibitor
- PIRTOBRUTINIB inhibitor
- RITLECITINIB TOSYLATE inhibitor
Neighborhood · nearest proteins
Related proteins · sequence + function similarity
- Tyrosine-protein kinase BTK 1.00
- Tyrosine-protein kinase BTK 0.99
- Tyrosine-protein kinase Tec 0.95
- Tyrosine-protein kinase Tec 0.95
- Tyrosine-protein kinase ITK/TSK 0.94
- Cytoplasmic tyrosine-protein kinase BMX 0.94
- Tyrosine-protein kinase ITK/TSK 0.93
- Tyrosine-protein kinase TXK 0.93
- Cytoplasmic tyrosine-protein kinase BMX 0.92
- Tyrosine-protein kinase FRK 0.91
- Tyrosine-protein kinase TXK 0.90
- Tyrosine-protein kinase transforming protein Abl 0.90
Co-cited proteins · studied together in the literature
- Tyrosine-protein kinase BTK 7 shared papers
- Inhibitor of Bruton tyrosine kinase 1 shared papers
- 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 2 shared papers
- Tyrosine-protein kinase BTK 3 shared papers
- SH3 domain-binding protein 5 2 shared papers
- General transcription factor II-I 2 shared papers
- Protein kinase C beta type 1 shared papers
- Toll/interleukin-1 receptor domain-containing adapter protein 1 shared papers
- Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 1 shared papers
- Cytoplasmic tyrosine-protein kinase BMX 2 shared papers
- SH3 domain-binding protein 5 1 shared papers
- Heterogeneous nuclear ribonucleoprotein H2 1 shared papers
Literature · 84 cited papers
- BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity. J. Exp. Med. · 2021
- N-terminome analysis of the human mitochondrial proteome. Proteomics · 2015
- Bruton's tyrosine kinase phosphorylates DDX41 and activates its binding of dsDNA and STING to initiate type 1 interferon response. Cell Rep. · 2015
- Functional characterization of BTK(C481S) mutation that confers ibrutinib resistance: exploration of alternative kinase inhibitors. Leukemia · 2015
- Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib. N. Engl. J. Med. · 2014
- Ibrutinib resistance in chronic lymphocytic leukemia. N. Engl. J. Med. · 2014
- Phosphorylated c-Mpl tyrosine 591 regulates thrombopoietin-induced signaling. Exp. Hematol. · 2014
- A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis. Genes Chromosomes Cancer · 2013
- Toward a comprehensive characterization of a human cancer cell phosphoproteome. J. Proteome Res. · 2013
- Insights into the conformational flexibility of Bruton's tyrosine kinase from multiple ligand complex structures. Protein Sci. · 2011
- Initial characterization of the human central proteome. BMC Syst. Biol. · 2011
- Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases. Protein Sci. · 2010
- … and 72 more in the literature graph